Part I. Infectious and Inflammatory Conditions: 1. Isolated angiitis of the central nervous system; 2. Temporal arteritis; 3. Varizella zoster and other virus-related cerebral vasculopathy; 4. Takayasu disease; 5. Bürger's disease (thrombangiitis obliterans); 6. Neurosyphilis and stroke; 7. Vasculitis and stroke due to tuberculosis; 8. Stroke due to fungal infections; 9. Stroke and vasculitis in patients with cysticercosis; 10. Stroke in patients with Lyme disease; 11. Behçet's disease; 12. Stroke and neurosarcoidosis; 13. Kawasaki disease: cerebrovascular and neurologic complications; 14. Cerebrovascular problems in Chagas' disease; 15. Stroke in persons infected with HIV; 16. Pulmonary arteriovenous malformations; Part II. Hereditary and Genetic Conditions and Malformations: 17. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease); 18. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL); 19.Cerebrovascular complications of Fabry's disease; 20. Marfan's syndrome; 21. Pseudoxanthoma elasticum; 22. Ehlers-Danlos syndrome; 23. Progeria; 24. MELAS and other mitochondrial disorders; 25. Sturge-Weber syndrome; 26. Von Hippel-Lindau disease; 27. Aneurysms; 28. Arteriovenous malformations of the brain; 29. Cerebral cavernous malformations and developmental venous anomalies; 30. Cerebrovascular manifestations of neurofibromatosis; 31. Menkes disease (kinky hair disease); 32. Wyburn-Mason syndrome; Part III. Vascular Conditions of the Eyes, Ears, and Brain: 33. Eales retinopathy; 34. Acute posterior multifocal placoid pigment epitheliopathy (APMPPE); 35. Microangiopathy of the retina, inner ear and brain: Susac's syndrome; 36. Hereditary endotheliopathy with retinopathy; nephropathy and stroke (HERNS); 37. Cogan's syndrome; Part IV. Disorders Involving Abnormal Coagulation: 38. Antiphospholipid antibody syndrome; 39. Disseminated intravascular disease; 40. Bleeding disorders and thrombophilia; 41. Thrombotic thrombocytopenic purpura; 42. Cerebrovascular complications of Henoch-Schönlein purpura; Part V. Systemic Disorders that Also Involve the Cerebrovasacular System: 43. Microscopic polyangiitis and polyarteritis nodosa; 44. Churg-Strauss syndrome; 45. Systemic lupus erythematosus; 46. Rheumatoid arthritis and cerebrovascular disease; 47. Hyperviscosity and stroke; 48. Calcium, hypercalcemia, magnesium, and brain ischemia; 49. Stroke and substance abuse; 50. Cancer and paraneoplastic strokes; 51. Kohlmeier-Degos' disease (malignant atrophic papulosis); 52. Stroke in patients who have inflammatory bowel disease; 53. Sweet's syndrome (acute febrile neutrophilic dermatosis); 54. Nephrotic syndrome and other renal diseases and stroke; 55. Epidermal nevus syndrome; 56. Sneddon's syndrome; 57. Metabolic causes of stroke; 58. Bone disorders and cerebrovascular disease; 59. Sclerederma; Part VI. Non-inflammatory Disorders of the Arterial Wall: 60. Cervico-cephalic arterial dissections; 61. Cerebral amyloid angiopathies; 62. Moya-moya syndrome; 63. Dilatative arteriopathy (dolichoectasia); 64. Paradoxical embolism and stroke; 65. Fibromuscular dysplasia; Part VII. Venous Occlusive Conditions: 66. Cerebral venous sinus thrombosis; Part VIII. Vasospastic Conditions and other Miscellaneous Vasculopathies: 67. Reversible cerebral vasoconstriction syndromes; 68. Eclampsia and stroke during pregnancy and the puerperium; 69. Migraine and migraine-like conditions; Part IX. Other Miscellaneous Conditions: 70. Intravascular lymphoma; 71. Other conditions.
